nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Estramustine—prostate cancer	0.454	1	CiPCiCtD
Trabectedin—SRC—prostate cancer	0.108	0.495	CbGaD
Trabectedin—CYP2E1—prostate cancer	0.0422	0.193	CbGaD
Trabectedin—CYP2C19—prostate cancer	0.0418	0.191	CbGaD
Trabectedin—CYP3A4—prostate cancer	0.0266	0.121	CbGaD
Trabectedin—CYP2C19—Bicalutamide—prostate cancer	0.0132	0.0685	CbGbCtD
Trabectedin—CYP2C19—Nilutamide—prostate cancer	0.0132	0.0685	CbGbCtD
Trabectedin—CYP2E1—Estrone—prostate cancer	0.0126	0.0655	CbGbCtD
Trabectedin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0121	0.063	CbGbCtD
Trabectedin—CYP2C9—Nilutamide—prostate cancer	0.011	0.0569	CbGbCtD
Trabectedin—CYP2C9—Bicalutamide—prostate cancer	0.011	0.0569	CbGbCtD
Trabectedin—CYP2C19—Flutamide—prostate cancer	0.0109	0.0567	CbGbCtD
Trabectedin—CYP2D6—Bicalutamide—prostate cancer	0.01	0.0521	CbGbCtD
Trabectedin—CYP2D6—Abiraterone—prostate cancer	0.00831	0.0431	CbGbCtD
Trabectedin—CYP2E1—Mitoxantrone—prostate cancer	0.0075	0.0389	CbGbCtD
Trabectedin—CYP2C9—Estrone—prostate cancer	0.00657	0.0341	CbGbCtD
Trabectedin—CYP3A4—Bicalutamide—prostate cancer	0.00638	0.0331	CbGbCtD
Trabectedin—PTGS1—Etoposide—prostate cancer	0.00612	0.0318	CbGbCtD
Trabectedin—CYP3A4—Estramustine—prostate cancer	0.00593	0.0308	CbGbCtD
Trabectedin—CYP3A4—Flutamide—prostate cancer	0.00529	0.0274	CbGbCtD
Trabectedin—CYP3A4—Abiraterone—prostate cancer	0.00529	0.0274	CbGbCtD
Trabectedin—CYP2C9—Capecitabine—prostate cancer	0.00498	0.0258	CbGbCtD
Trabectedin—CYP2E1—Etoposide—prostate cancer	0.00473	0.0245	CbGbCtD
Trabectedin—CYP2C19—Estradiol—prostate cancer	0.00454	0.0236	CbGbCtD
Trabectedin—CYP3A4—Cabazitaxel—prostate cancer	0.00391	0.0203	CbGbCtD
Trabectedin—CYP2C19—Prednisone—prostate cancer	0.0039	0.0203	CbGbCtD
Trabectedin—CYP3A4—Estrone—prostate cancer	0.00382	0.0198	CbGbCtD
Trabectedin—CYP2C9—Estradiol—prostate cancer	0.00377	0.0196	CbGbCtD
Trabectedin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00341	0.0177	CbGbCtD
Trabectedin—CYP3A4—Conjugated Estrogens—prostate cancer	0.0025	0.013	CbGbCtD
Trabectedin—CYP3A4—Mitoxantrone—prostate cancer	0.00227	0.0118	CbGbCtD
Trabectedin—CYP3A4—Estradiol—prostate cancer	0.00219	0.0114	CbGbCtD
Trabectedin—CYP3A4—Prednisone—prostate cancer	0.00189	0.0098	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—prostate cancer	0.00154	0.00798	CbGbCtD
Trabectedin—CYP3A4—Etoposide—prostate cancer	0.00143	0.00744	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—prostate cancer	0.00131	0.00681	CbGbCtD
Trabectedin—CYP2C19—urine—prostate cancer	0.00118	0.122	CbGeAlD
Trabectedin—CYP3A4—Doxorubicin—prostate cancer	0.000977	0.00507	CbGbCtD
Trabectedin—CYP2C9—urine—prostate cancer	0.000916	0.0945	CbGeAlD
Trabectedin—CYP2E1—urine—prostate cancer	0.000868	0.0895	CbGeAlD
Trabectedin—SRC—prostate gland—prostate cancer	0.000804	0.083	CbGeAlD
Trabectedin—CYP3A4—urine—prostate cancer	0.000698	0.072	CbGeAlD
Trabectedin—CYP2D6—urine—prostate cancer	0.000687	0.0709	CbGeAlD
Trabectedin—SRC—epithelium—prostate cancer	0.000591	0.061	CbGeAlD
Trabectedin—SRC—renal system—prostate cancer	0.000548	0.0565	CbGeAlD
Trabectedin—SRC—testis—prostate cancer	0.000354	0.0365	CbGeAlD
Trabectedin—CYP2E1—prostate gland—prostate cancer	0.000312	0.0321	CbGeAlD
Trabectedin—PTGS1—prostate gland—prostate cancer	0.0003	0.031	CbGeAlD
Trabectedin—CYP2E1—seminal vesicle—prostate cancer	0.000263	0.0272	CbGeAlD
Trabectedin—SRC—lymph node—prostate cancer	0.000257	0.0265	CbGeAlD
Trabectedin—PTGS1—seminal vesicle—prostate cancer	0.000254	0.0262	CbGeAlD
Trabectedin—PTGS1—epithelium—prostate cancer	0.000221	0.0228	CbGeAlD
Trabectedin—CYP2E1—renal system—prostate cancer	0.000212	0.0219	CbGeAlD
Trabectedin—CYP2E1—urethra—prostate cancer	0.000209	0.0215	CbGeAlD
Trabectedin—PTGS1—renal system—prostate cancer	0.000205	0.0211	CbGeAlD
Trabectedin—CYP3A4—renal system—prostate cancer	0.000171	0.0176	CbGeAlD
Trabectedin—CYP2D6—renal system—prostate cancer	0.000168	0.0173	CbGeAlD
Trabectedin—CYP2E1—testis—prostate cancer	0.000137	0.0142	CbGeAlD
Trabectedin—PTGS1—testis—prostate cancer	0.000132	0.0136	CbGeAlD
Trabectedin—CYP2D6—testis—prostate cancer	0.000109	0.0112	CbGeAlD
Trabectedin—PTGS1—lymph node—prostate cancer	9.58e-05	0.00989	CbGeAlD
Trabectedin—Loss of consciousness—Docetaxel—prostate cancer	2.91e-05	0.000419	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—prostate cancer	2.9e-05	0.000417	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—prostate cancer	2.9e-05	0.000417	CcSEcCtD
Trabectedin—Alopecia—Prednisone—prostate cancer	2.9e-05	0.000417	CcSEcCtD
Trabectedin—Cough—Docetaxel—prostate cancer	2.89e-05	0.000416	CcSEcCtD
Trabectedin—Hypersensitivity—Mitoxantrone—prostate cancer	2.88e-05	0.000414	CcSEcCtD
Trabectedin—Syncope—Capecitabine—prostate cancer	2.88e-05	0.000413	CcSEcCtD
Trabectedin—Mental disorder—Prednisone—prostate cancer	2.88e-05	0.000413	CcSEcCtD
Trabectedin—Diarrhoea—Estradiol—prostate cancer	2.87e-05	0.000413	CcSEcCtD
Trabectedin—Leukopenia—Capecitabine—prostate cancer	2.87e-05	0.000413	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—prostate cancer	2.86e-05	0.000411	CcSEcCtD
Trabectedin—Infestation—Epirubicin—prostate cancer	2.86e-05	0.000411	CcSEcCtD
Trabectedin—Malnutrition—Prednisone—prostate cancer	2.86e-05	0.000411	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—prostate cancer	2.83e-05	0.000407	CcSEcCtD
Trabectedin—Arthralgia—Docetaxel—prostate cancer	2.82e-05	0.000405	CcSEcCtD
Trabectedin—Myalgia—Docetaxel—prostate cancer	2.82e-05	0.000405	CcSEcCtD
Trabectedin—Loss of consciousness—Capecitabine—prostate cancer	2.82e-05	0.000405	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—prostate cancer	2.82e-05	0.000405	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—prostate cancer	2.81e-05	0.000404	CcSEcCtD
Trabectedin—Asthenia—Mitoxantrone—prostate cancer	2.81e-05	0.000403	CcSEcCtD
Trabectedin—Fatigue—Etoposide—prostate cancer	2.81e-05	0.000403	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	2.8e-05	0.000403	CcSEcCtD
Trabectedin—Cough—Capecitabine—prostate cancer	2.8e-05	0.000402	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—prostate cancer	2.79e-05	0.000401	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—prostate cancer	2.79e-05	0.000401	CcSEcCtD
Trabectedin—Constipation—Etoposide—prostate cancer	2.78e-05	0.0004	CcSEcCtD
Trabectedin—Dizziness—Estradiol—prostate cancer	2.78e-05	0.000399	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—prostate cancer	2.78e-05	0.000399	CcSEcCtD
Trabectedin—Arthralgia—Capecitabine—prostate cancer	2.73e-05	0.000393	CcSEcCtD
Trabectedin—Myalgia—Capecitabine—prostate cancer	2.73e-05	0.000393	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.71e-05	0.00039	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—prostate cancer	2.71e-05	0.000389	CcSEcCtD
Trabectedin—Oedema—Docetaxel—prostate cancer	2.71e-05	0.000389	CcSEcCtD
Trabectedin—Infection—Docetaxel—prostate cancer	2.69e-05	0.000386	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—prostate cancer	2.69e-05	0.000386	CcSEcCtD
Trabectedin—Diarrhoea—Mitoxantrone—prostate cancer	2.68e-05	0.000385	CcSEcCtD
Trabectedin—Vomiting—Estradiol—prostate cancer	2.67e-05	0.000384	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—prostate cancer	2.67e-05	0.000384	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—prostate cancer	2.66e-05	0.000382	CcSEcCtD
Trabectedin—Shock—Docetaxel—prostate cancer	2.66e-05	0.000382	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—prostate cancer	2.65e-05	0.000381	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—prostate cancer	2.65e-05	0.000381	CcSEcCtD
Trabectedin—Rash—Estradiol—prostate cancer	2.65e-05	0.00038	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—prostate cancer	2.65e-05	0.00038	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—prostate cancer	2.65e-05	0.00038	CcSEcCtD
Trabectedin—Dermatitis—Estradiol—prostate cancer	2.65e-05	0.00038	CcSEcCtD
Trabectedin—Anaemia—Prednisone—prostate cancer	2.64e-05	0.00038	CcSEcCtD
Trabectedin—Headache—Estradiol—prostate cancer	2.63e-05	0.000378	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—prostate cancer	2.63e-05	0.000378	CcSEcCtD
Trabectedin—Oedema—Capecitabine—prostate cancer	2.62e-05	0.000376	CcSEcCtD
Trabectedin—Infection—Capecitabine—prostate cancer	2.6e-05	0.000374	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—prostate cancer	2.58e-05	0.000371	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—prostate cancer	2.58e-05	0.000371	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—prostate cancer	2.58e-05	0.000371	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—prostate cancer	2.58e-05	0.00037	CcSEcCtD
Trabectedin—Shock—Capecitabine—prostate cancer	2.58e-05	0.00037	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—prostate cancer	2.57e-05	0.00037	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—prostate cancer	2.57e-05	0.00037	CcSEcCtD
Trabectedin—Nervous system disorder—Capecitabine—prostate cancer	2.57e-05	0.000369	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—prostate cancer	2.57e-05	0.000369	CcSEcCtD
Trabectedin—Thrombocytopenia—Capecitabine—prostate cancer	2.56e-05	0.000368	CcSEcCtD
Trabectedin—Syncope—Prednisone—prostate cancer	2.56e-05	0.000368	CcSEcCtD
Trabectedin—Skin disorder—Capecitabine—prostate cancer	2.54e-05	0.000366	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—prostate cancer	2.53e-05	0.000364	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—prostate cancer	2.53e-05	0.000363	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—prostate cancer	2.52e-05	0.000363	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisone—prostate cancer	2.51e-05	0.000361	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—prostate cancer	2.5e-05	0.00036	CcSEcCtD
Trabectedin—Anorexia—Capecitabine—prostate cancer	2.5e-05	0.000359	CcSEcCtD
Trabectedin—Nausea—Estradiol—prostate cancer	2.49e-05	0.000358	CcSEcCtD
Trabectedin—Vomiting—Mitoxantrone—prostate cancer	2.49e-05	0.000357	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—prostate cancer	2.47e-05	0.000355	CcSEcCtD
Trabectedin—Rash—Mitoxantrone—prostate cancer	2.47e-05	0.000355	CcSEcCtD
Trabectedin—Dermatitis—Mitoxantrone—prostate cancer	2.47e-05	0.000354	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.46e-05	0.000354	CcSEcCtD
Trabectedin—Headache—Mitoxantrone—prostate cancer	2.45e-05	0.000352	CcSEcCtD
Trabectedin—Hypotension—Capecitabine—prostate cancer	2.45e-05	0.000352	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—prostate cancer	2.45e-05	0.000352	CcSEcCtD
Trabectedin—Myalgia—Prednisone—prostate cancer	2.43e-05	0.00035	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—prostate cancer	2.43e-05	0.00035	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—prostate cancer	2.43e-05	0.000349	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.42e-05	0.000347	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—prostate cancer	2.41e-05	0.000347	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—prostate cancer	2.4e-05	0.000345	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—prostate cancer	2.39e-05	0.000343	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.39e-05	0.000343	CcSEcCtD
Trabectedin—Flushing—Epirubicin—prostate cancer	2.38e-05	0.000342	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—prostate cancer	2.38e-05	0.000342	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—prostate cancer	2.38e-05	0.000341	CcSEcCtD
Trabectedin—Insomnia—Capecitabine—prostate cancer	2.37e-05	0.00034	CcSEcCtD
Trabectedin—Paraesthesia—Capecitabine—prostate cancer	2.35e-05	0.000338	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—prostate cancer	2.35e-05	0.000338	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—prostate cancer	2.34e-05	0.000336	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—prostate cancer	2.34e-05	0.000336	CcSEcCtD
Trabectedin—Asthenia—Etoposide—prostate cancer	2.34e-05	0.000336	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—prostate cancer	2.34e-05	0.000336	CcSEcCtD
Trabectedin—Dyspnoea—Capecitabine—prostate cancer	2.34e-05	0.000335	CcSEcCtD
Trabectedin—Oedema—Prednisone—prostate cancer	2.33e-05	0.000335	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—prostate cancer	2.33e-05	0.000335	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—prostate cancer	2.33e-05	0.000335	CcSEcCtD
Trabectedin—Nausea—Mitoxantrone—prostate cancer	2.32e-05	0.000334	CcSEcCtD
Trabectedin—Infection—Prednisone—prostate cancer	2.32e-05	0.000333	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—prostate cancer	2.31e-05	0.000333	CcSEcCtD
Trabectedin—Constipation—Docetaxel—prostate cancer	2.31e-05	0.000332	CcSEcCtD
Trabectedin—Dyspepsia—Capecitabine—prostate cancer	2.31e-05	0.000331	CcSEcCtD
Trabectedin—Shock—Prednisone—prostate cancer	2.3e-05	0.00033	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—prostate cancer	2.29e-05	0.000329	CcSEcCtD
Trabectedin—Decreased appetite—Capecitabine—prostate cancer	2.28e-05	0.000327	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—prostate cancer	2.27e-05	0.000326	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—prostate cancer	2.27e-05	0.000326	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Capecitabine—prostate cancer	2.26e-05	0.000325	CcSEcCtD
Trabectedin—Fatigue—Capecitabine—prostate cancer	2.26e-05	0.000324	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—prostate cancer	2.25e-05	0.000323	CcSEcCtD
Trabectedin—Constipation—Capecitabine—prostate cancer	2.24e-05	0.000322	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—prostate cancer	2.24e-05	0.000321	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—prostate cancer	2.23e-05	0.00032	CcSEcCtD
Trabectedin—Anorexia—Prednisone—prostate cancer	2.22e-05	0.00032	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—prostate cancer	2.21e-05	0.000318	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—prostate cancer	2.21e-05	0.000317	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—prostate cancer	2.19e-05	0.000315	CcSEcCtD
Trabectedin—Back pain—Epirubicin—prostate cancer	2.16e-05	0.000311	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—prostate cancer	2.16e-05	0.00031	CcSEcCtD
Trabectedin—Dizziness—Etoposide—prostate cancer	2.15e-05	0.000309	CcSEcCtD
Trabectedin—Gastrointestinal pain—Capecitabine—prostate cancer	2.14e-05	0.000308	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—prostate cancer	2.14e-05	0.000308	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—prostate cancer	2.14e-05	0.000307	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—prostate cancer	2.14e-05	0.000307	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.13e-05	0.000305	CcSEcCtD
Trabectedin—Insomnia—Prednisone—prostate cancer	2.11e-05	0.000303	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—prostate cancer	2.1e-05	0.000302	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—prostate cancer	2.1e-05	0.000301	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—prostate cancer	2.08e-05	0.000299	CcSEcCtD
Trabectedin—Body temperature increased—Capecitabine—prostate cancer	2.07e-05	0.000297	CcSEcCtD
Trabectedin—Abdominal pain—Capecitabine—prostate cancer	2.07e-05	0.000297	CcSEcCtD
Trabectedin—Vomiting—Etoposide—prostate cancer	2.07e-05	0.000297	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—prostate cancer	2.07e-05	0.000297	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—prostate cancer	2.07e-05	0.000297	CcSEcCtD
Trabectedin—Dyspepsia—Prednisone—prostate cancer	2.05e-05	0.000295	CcSEcCtD
Trabectedin—Rash—Etoposide—prostate cancer	2.05e-05	0.000295	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—prostate cancer	2.05e-05	0.000295	CcSEcCtD
Trabectedin—Headache—Etoposide—prostate cancer	2.04e-05	0.000293	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—prostate cancer	2.03e-05	0.000291	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—prostate cancer	2.03e-05	0.000291	CcSEcCtD
Trabectedin—Fatigue—Prednisone—prostate cancer	2.01e-05	0.000289	CcSEcCtD
Trabectedin—Syncope—Epirubicin—prostate cancer	2.01e-05	0.000288	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—prostate cancer	2e-05	0.000288	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—prostate cancer	2e-05	0.000287	CcSEcCtD
Trabectedin—Constipation—Prednisone—prostate cancer	2e-05	0.000287	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—prostate cancer	1.99e-05	0.000286	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—prostate cancer	1.97e-05	0.000282	CcSEcCtD
Trabectedin—Cough—Epirubicin—prostate cancer	1.95e-05	0.00028	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—prostate cancer	1.94e-05	0.000279	CcSEcCtD
Trabectedin—Nausea—Etoposide—prostate cancer	1.93e-05	0.000278	CcSEcCtD
Trabectedin—Hypersensitivity—Capecitabine—prostate cancer	1.93e-05	0.000277	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—prostate cancer	1.91e-05	0.000275	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—prostate cancer	1.91e-05	0.000274	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—prostate cancer	1.9e-05	0.000273	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—prostate cancer	1.9e-05	0.000273	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.89e-05	0.000272	CcSEcCtD
Trabectedin—Asthenia—Capecitabine—prostate cancer	1.88e-05	0.00027	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—prostate cancer	1.86e-05	0.000267	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—prostate cancer	1.85e-05	0.000266	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—prostate cancer	1.85e-05	0.000266	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—prostate cancer	1.84e-05	0.000265	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—prostate cancer	1.84e-05	0.000265	CcSEcCtD
Trabectedin—Oedema—Epirubicin—prostate cancer	1.82e-05	0.000262	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—prostate cancer	1.82e-05	0.000261	CcSEcCtD
Trabectedin—Infection—Epirubicin—prostate cancer	1.81e-05	0.00026	CcSEcCtD
Trabectedin—Cough—Doxorubicin—prostate cancer	1.81e-05	0.000259	CcSEcCtD
Trabectedin—Shock—Epirubicin—prostate cancer	1.8e-05	0.000258	CcSEcCtD
Trabectedin—Diarrhoea—Capecitabine—prostate cancer	1.79e-05	0.000257	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—prostate cancer	1.79e-05	0.000257	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—prostate cancer	1.79e-05	0.000257	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—prostate cancer	1.79e-05	0.000257	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—prostate cancer	1.77e-05	0.000255	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—prostate cancer	1.76e-05	0.000253	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—prostate cancer	1.76e-05	0.000253	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.75e-05	0.000251	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—prostate cancer	1.74e-05	0.00025	CcSEcCtD
Trabectedin—Dizziness—Capecitabine—prostate cancer	1.73e-05	0.000249	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—prostate cancer	1.72e-05	0.000247	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—prostate cancer	1.72e-05	0.000247	CcSEcCtD
Trabectedin—Rash—Docetaxel—prostate cancer	1.71e-05	0.000245	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—prostate cancer	1.71e-05	0.000245	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—prostate cancer	1.7e-05	0.000245	CcSEcCtD
Trabectedin—Headache—Docetaxel—prostate cancer	1.69e-05	0.000243	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—prostate cancer	1.69e-05	0.000243	CcSEcCtD
Trabectedin—Infection—Doxorubicin—prostate cancer	1.68e-05	0.000241	CcSEcCtD
Trabectedin—Asthenia—Prednisone—prostate cancer	1.67e-05	0.00024	CcSEcCtD
Trabectedin—Vomiting—Capecitabine—prostate cancer	1.67e-05	0.000239	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.66e-05	0.000239	CcSEcCtD
Trabectedin—Shock—Doxorubicin—prostate cancer	1.66e-05	0.000239	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—prostate cancer	1.66e-05	0.000238	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—prostate cancer	1.65e-05	0.000237	CcSEcCtD
Trabectedin—Rash—Capecitabine—prostate cancer	1.65e-05	0.000237	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—prostate cancer	1.65e-05	0.000237	CcSEcCtD
Trabectedin—Dermatitis—Capecitabine—prostate cancer	1.65e-05	0.000237	CcSEcCtD
Trabectedin—Headache—Capecitabine—prostate cancer	1.64e-05	0.000236	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—prostate cancer	1.64e-05	0.000236	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—prostate cancer	1.64e-05	0.000235	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—prostate cancer	1.63e-05	0.000234	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—prostate cancer	1.61e-05	0.000231	CcSEcCtD
Trabectedin—Nausea—Docetaxel—prostate cancer	1.61e-05	0.000231	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—prostate cancer	1.61e-05	0.000231	CcSEcCtD
Trabectedin—Diarrhoea—Prednisone—prostate cancer	1.6e-05	0.000229	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—prostate cancer	1.59e-05	0.000228	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—prostate cancer	1.58e-05	0.000227	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.58e-05	0.000226	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—prostate cancer	1.57e-05	0.000226	CcSEcCtD
Trabectedin—Constipation—Epirubicin—prostate cancer	1.56e-05	0.000224	CcSEcCtD
Trabectedin—Nausea—Capecitabine—prostate cancer	1.56e-05	0.000224	CcSEcCtD
Trabectedin—Dizziness—Prednisone—prostate cancer	1.54e-05	0.000222	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.54e-05	0.000221	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—prostate cancer	1.53e-05	0.000219	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—prostate cancer	1.52e-05	0.000218	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—prostate cancer	1.51e-05	0.000216	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—prostate cancer	1.49e-05	0.000214	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—prostate cancer	1.49e-05	0.000214	CcSEcCtD
Trabectedin—Vomiting—Prednisone—prostate cancer	1.48e-05	0.000213	CcSEcCtD
Trabectedin—Rash—Prednisone—prostate cancer	1.47e-05	0.000211	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—prostate cancer	1.47e-05	0.000211	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—prostate cancer	1.47e-05	0.000211	CcSEcCtD
Trabectedin—Headache—Prednisone—prostate cancer	1.46e-05	0.00021	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.46e-05	0.000209	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—prostate cancer	1.46e-05	0.000209	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—prostate cancer	1.44e-05	0.000207	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—prostate cancer	1.44e-05	0.000207	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—prostate cancer	1.44e-05	0.000207	CcSEcCtD
Trabectedin—Nausea—Prednisone—prostate cancer	1.39e-05	0.000199	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.38e-05	0.000198	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—prostate cancer	1.34e-05	0.000193	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—prostate cancer	1.33e-05	0.000192	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—prostate cancer	1.33e-05	0.000192	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—prostate cancer	1.31e-05	0.000188	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—prostate cancer	1.25e-05	0.000179	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—prostate cancer	1.24e-05	0.000179	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—prostate cancer	1.21e-05	0.000174	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—prostate cancer	1.21e-05	0.000173	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—prostate cancer	1.16e-05	0.000167	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—prostate cancer	1.16e-05	0.000166	CcSEcCtD
Trabectedin—Rash—Epirubicin—prostate cancer	1.15e-05	0.000165	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—prostate cancer	1.15e-05	0.000165	CcSEcCtD
Trabectedin—Headache—Epirubicin—prostate cancer	1.14e-05	0.000164	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—prostate cancer	1.12e-05	0.00016	CcSEcCtD
Trabectedin—Nausea—Epirubicin—prostate cancer	1.08e-05	0.000156	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—prostate cancer	1.07e-05	0.000154	CcSEcCtD
Trabectedin—Rash—Doxorubicin—prostate cancer	1.06e-05	0.000153	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—prostate cancer	1.06e-05	0.000153	CcSEcCtD
Trabectedin—Headache—Doxorubicin—prostate cancer	1.06e-05	0.000152	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—prostate cancer	1e-05	0.000144	CcSEcCtD
Trabectedin—CYP3A4—Metabolism—GSTO1—prostate cancer	1.31e-06	2.38e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—prostate cancer	1.31e-06	2.38e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS3—prostate cancer	1.31e-06	2.38e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CB—prostate cancer	1.31e-06	2.38e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.31e-06	2.38e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GGT1—prostate cancer	1.31e-06	2.37e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.3e-06	2.36e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NQO1—prostate cancer	1.3e-06	2.35e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CREBBP—prostate cancer	1.29e-06	2.34e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NCOA1—prostate cancer	1.29e-06	2.34e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NQO1—prostate cancer	1.28e-06	2.33e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TH—prostate cancer	1.28e-06	2.32e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—JAK2—prostate cancer	1.27e-06	2.31e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.27e-06	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—prostate cancer	1.27e-06	2.3e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TH—prostate cancer	1.27e-06	2.3e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.26e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLCB2—prostate cancer	1.26e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—LRP2—prostate cancer	1.26e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.26e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.26e-06	2.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—prostate cancer	1.26e-06	2.28e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.25e-06	2.27e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.25e-06	2.26e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—prostate cancer	1.24e-06	2.26e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—prostate cancer	1.24e-06	2.26e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.24e-06	2.25e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—prostate cancer	1.24e-06	2.24e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—P4HB—prostate cancer	1.24e-06	2.24e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.23e-06	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—prostate cancer	1.23e-06	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—prostate cancer	1.23e-06	2.22e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RXRA—prostate cancer	1.23e-06	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—LEP—prostate cancer	1.23e-06	2.22e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—prostate cancer	1.22e-06	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—prostate cancer	1.21e-06	2.2e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CAV1—prostate cancer	1.21e-06	2.2e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARA—prostate cancer	1.21e-06	2.2e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—prostate cancer	1.21e-06	2.19e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—prostate cancer	1.2e-06	2.18e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GGT1—prostate cancer	1.2e-06	2.18e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.2e-06	2.18e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—prostate cancer	1.2e-06	2.18e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—prostate cancer	1.2e-06	2.17e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GGT1—prostate cancer	1.19e-06	2.16e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.19e-06	2.16e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NCOA1—prostate cancer	1.19e-06	2.15e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—COMT—prostate cancer	1.18e-06	2.14e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTP1—prostate cancer	1.18e-06	2.13e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NCOA1—prostate cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—prostate cancer	1.17e-06	2.12e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.17e-06	2.12e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—prostate cancer	1.16e-06	2.11e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.16e-06	2.1e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ITPR1—prostate cancer	1.16e-06	2.1e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NOS3—prostate cancer	1.15e-06	2.09e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MED12—prostate cancer	1.15e-06	2.09e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNG5—prostate cancer	1.14e-06	2.07e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BAD—prostate cancer	1.14e-06	2.07e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CAV1—prostate cancer	1.14e-06	2.07e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.14e-06	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—prostate cancer	1.14e-06	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—prostate cancer	1.14e-06	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—prostate cancer	1.13e-06	2.05e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RXRA—prostate cancer	1.13e-06	2.04e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—prostate cancer	1.12e-06	2.03e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RXRA—prostate cancer	1.12e-06	2.03e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APC—prostate cancer	1.11e-06	2.01e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—prostate cancer	1.11e-06	2.01e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA3—prostate cancer	1.1e-06	2e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGF—prostate cancer	1.09e-06	1.98e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IRS1—prostate cancer	1.09e-06	1.98e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—prostate cancer	1.09e-06	1.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.09e-06	1.97e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—COMT—prostate cancer	1.09e-06	1.97e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTP1—prostate cancer	1.08e-06	1.96e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—prostate cancer	1.08e-06	1.96e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—prostate cancer	1.08e-06	1.96e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—COMT—prostate cancer	1.08e-06	1.95e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—prostate cancer	1.08e-06	1.95e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—prostate cancer	1.07e-06	1.95e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTP1—prostate cancer	1.07e-06	1.94e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—prostate cancer	1.07e-06	1.93e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ITPR1—prostate cancer	1.06e-06	1.93e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GSK3B—prostate cancer	1.06e-06	1.92e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—LPL—prostate cancer	1.06e-06	1.92e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—prostate cancer	1.06e-06	1.91e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ITPR1—prostate cancer	1.05e-06	1.91e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HPGDS—prostate cancer	1.05e-06	1.91e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—prostate cancer	1.05e-06	1.9e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—INS—prostate cancer	1.05e-06	1.9e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—prostate cancer	1.05e-06	1.9e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.04e-06	1.89e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.04e-06	1.88e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.04e-06	1.88e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREBBP—prostate cancer	1.03e-06	1.86e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.02e-06	1.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ACHE—prostate cancer	1.02e-06	1.85e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—prostate cancer	1.02e-06	1.85e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ERCC2—prostate cancer	1.02e-06	1.84e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—prostate cancer	1.01e-06	1.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1—prostate cancer	1.01e-06	1.84e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.01e-06	1.83e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—prostate cancer	1e-06	1.82e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—prostate cancer	9.97e-07	1.81e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—prostate cancer	9.96e-07	1.81e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—prostate cancer	9.93e-07	1.8e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—prostate cancer	9.85e-07	1.79e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—INS—prostate cancer	9.84e-07	1.78e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKR1C3—prostate cancer	9.8e-07	1.78e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAP2K1—prostate cancer	9.79e-07	1.78e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRKACB—prostate cancer	9.75e-07	1.77e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—LPL—prostate cancer	9.75e-07	1.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—prostate cancer	9.72e-07	1.76e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—LPL—prostate cancer	9.66e-07	1.75e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.65e-07	1.75e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CREBBP—prostate cancer	9.64e-07	1.75e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SERPINE1—prostate cancer	9.62e-07	1.74e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—prostate cancer	9.54e-07	1.73e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1A1—prostate cancer	9.42e-07	1.71e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARA—prostate cancer	9.36e-07	1.7e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—prostate cancer	9.35e-07	1.7e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ERCC2—prostate cancer	9.34e-07	1.69e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.33e-07	1.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGF2—prostate cancer	9.31e-07	1.69e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ERCC2—prostate cancer	9.26e-07	1.68e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—prostate cancer	9.21e-07	1.67e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—prostate cancer	9.21e-07	1.67e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA2—prostate cancer	9.2e-07	1.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOS3—prostate cancer	9.18e-07	1.67e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—prostate cancer	9.14e-07	1.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAK2—prostate cancer	8.92e-07	1.62e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CAV1—prostate cancer	8.8e-07	1.6e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—prostate cancer	8.78e-07	1.59e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—prostate cancer	8.78e-07	1.59e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—prostate cancer	8.77e-07	1.59e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—prostate cancer	8.71e-07	1.58e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—prostate cancer	8.7e-07	1.58e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—prostate cancer	8.7e-07	1.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—prostate cancer	8.69e-07	1.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—prostate cancer	8.67e-07	1.57e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NOS3—prostate cancer	8.63e-07	1.56e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARA—prostate cancer	8.61e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—prostate cancer	8.59e-07	1.56e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.57e-07	1.55e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARA—prostate cancer	8.54e-07	1.55e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—prostate cancer	8.5e-07	1.54e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—prostate cancer	8.48e-07	1.54e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NQO1—prostate cancer	8.47e-07	1.54e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.41e-07	1.53e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TH—prostate cancer	8.35e-07	1.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—prostate cancer	8.14e-07	1.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.12e-07	1.47e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CAV1—prostate cancer	8.1e-07	1.47e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—prostate cancer	8.03e-07	1.46e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CAV1—prostate cancer	8.03e-07	1.46e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.02e-07	1.45e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—prostate cancer	7.99e-07	1.45e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—prostate cancer	7.96e-07	1.44e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—prostate cancer	7.95e-07	1.44e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—prostate cancer	7.89e-07	1.43e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GGT1—prostate cancer	7.87e-07	1.43e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—prostate cancer	7.8e-07	1.41e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—prostate cancer	7.78e-07	1.41e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA1—prostate cancer	7.75e-07	1.41e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.67e-07	1.39e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.64e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—INS—prostate cancer	7.59e-07	1.38e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—prostate cancer	7.59e-07	1.38e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—prostate cancer	7.51e-07	1.36e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CREBBP—prostate cancer	7.43e-07	1.35e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—prostate cancer	7.38e-07	1.34e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—prostate cancer	7.37e-07	1.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RXRA—prostate cancer	7.37e-07	1.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—prostate cancer	7.37e-07	1.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—prostate cancer	7.34e-07	1.33e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—prostate cancer	7.32e-07	1.33e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.31e-07	1.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—COMT—prostate cancer	7.1e-07	1.29e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—prostate cancer	7.08e-07	1.28e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTP1—prostate cancer	7.07e-07	1.28e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.05e-07	1.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—prostate cancer	6.98e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—INS—prostate cancer	6.98e-07	1.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ITPR1—prostate cancer	6.95e-07	1.26e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—INS—prostate cancer	6.92e-07	1.26e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—prostate cancer	6.88e-07	1.25e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CREBBP—prostate cancer	6.84e-07	1.24e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CREBBP—prostate cancer	6.78e-07	1.23e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NOS3—prostate cancer	6.66e-07	1.21e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—prostate cancer	6.61e-07	1.2e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—prostate cancer	6.57e-07	1.19e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—prostate cancer	6.56e-07	1.19e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—prostate cancer	6.55e-07	1.19e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—prostate cancer	6.53e-07	1.18e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—prostate cancer	6.53e-07	1.18e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—prostate cancer	6.5e-07	1.18e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—prostate cancer	6.49e-07	1.18e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.48e-07	1.18e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.43e-07	1.17e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—LPL—prostate cancer	6.37e-07	1.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.16e-07	1.12e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.14e-07	1.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NOS3—prostate cancer	6.12e-07	1.11e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ERCC2—prostate cancer	6.11e-07	1.11e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—prostate cancer	6.09e-07	1.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—prostate cancer	6.09e-07	1.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—prostate cancer	6.07e-07	1.1e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NOS3—prostate cancer	6.07e-07	1.1e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—prostate cancer	6.03e-07	1.09e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—prostate cancer	5.95e-07	1.08e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—prostate cancer	5.74e-07	1.04e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.65e-07	1.02e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARA—prostate cancer	5.63e-07	1.02e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—prostate cancer	5.62e-07	1.02e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.6e-07	1.02e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—prostate cancer	5.6e-07	1.02e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—prostate cancer	5.55e-07	1.01e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—prostate cancer	5.31e-07	9.63e-06	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—prostate cancer	5.31e-07	9.62e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CAV1—prostate cancer	5.29e-07	9.6e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—prostate cancer	5.17e-07	9.37e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—prostate cancer	5.06e-07	9.18e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—prostate cancer	5e-07	9.06e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—prostate cancer	4.88e-07	8.86e-06	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.85e-07	8.8e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—prostate cancer	4.84e-07	8.78e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.82e-07	8.74e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—prostate cancer	4.66e-07	8.44e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—prostate cancer	4.62e-07	8.37e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—prostate cancer	4.58e-07	8.3e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—INS—prostate cancer	4.56e-07	8.28e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CREBBP—prostate cancer	4.47e-07	8.11e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.24e-07	7.69e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—prostate cancer	4.22e-07	7.65e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NOS3—prostate cancer	4e-07	7.26e-06	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—prostate cancer	3.97e-07	7.19e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.75e-07	6.79e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.69e-07	6.7e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—prostate cancer	3.66e-07	6.64e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.44e-07	6.25e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.42e-07	6.19e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—prostate cancer	3.19e-07	5.79e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—prostate cancer	3.06e-07	5.55e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—prostate cancer	3.04e-07	5.52e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—prostate cancer	2.81e-07	5.1e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—prostate cancer	2.79e-07	5.06e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.25e-07	4.08e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—prostate cancer	1.84e-07	3.34e-06	CbGpPWpGaD
